IPCA Labs shares surge to a record high after Motilal upgrade, target ₹1,950

Motilal has upgraded IPCA Laboratories to buy as the brokerage has factored in better operational efficiency, a revival in US business, synergies from the Unichem acquisition, and well-established DF business.

Leave a Reply

Your email address will not be published. Required fields are marked *